Skip to main content

Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Executive Vice President and Chief Financial Officer Sam Eldessouky and Chief Medical Officer and Head of Research & Development Yehia Hashad, MD, will participate in a company presentation at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 1:30 p.m. PT (4:30 p.m. ET).

A live webcast and audio archive of the event will be available on the Investor Relations page of the Bausch + Lomb website: http://ir.bausch.com/investors/events-presentations.

About Bausch + Lomb

Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

© 2026 Bausch + Lomb.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.83
+2.40 (1.05%)
AAPL  270.68
-0.30 (-0.11%)
AMD  215.45
+0.50 (0.23%)
BAC  56.11
+0.23 (0.41%)
GOOG  312.86
+1.53 (0.49%)
META  662.54
+1.04 (0.16%)
MSFT  486.21
+1.29 (0.27%)
NVDA  183.88
+0.19 (0.10%)
ORCL  194.34
-4.04 (-2.04%)
TSLA  486.88
-1.85 (-0.38%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.